AmpliPhi Biosciences
Biotechnology-Research
Website
Company Tagline
AmpliPhi Biosciences and C3J Therapeutics complete merger and formation of Armata Pharmaceuticals
Industry Category
Business Keywords
Company Description
AmpliPhi Biosciences is now part of Armata Pharmaceuticals, a biotechnology research company dedicated to combating antimicrobial-resistant bacterial infections. Located at 4503 Glencoe Ave, Marina del Rey, California 90292, US, Armata Pharmaceuticals is driven by rigorous and innovative science, developing high-impact, best-in-class bacteriophage therapeutics with the potential to save millions of lives.
AmpliPhi Biosciences' legacy and expertise in phage therapy have been integrated into Armata Pharmaceuticals, focusing on pioneering solutions to address the global threat of antimicrobial resistance. Armata Pharmaceuticals is committed to advancing the field through cutting-edge research and development, ensuring the delivery of effective and innovative treatments.
We invite the manager of AmpliPhi Biosciences to create a customized and exclusive company showcase and product listing on our platform, highlighting the company's contributions to biotechnology research and Armata Pharmaceuticals' ongoing mission.
AmpliPhi Biosciences fait désormais partie d'Armata Pharmaceuticals, une société de recherche biotechnologique dédiée à la lutte contre les infections bactériennes résistantes aux antimicrobiens. Située au 4503 Glencoe Ave, Marina del Rey, Californie 90292, États-Unis, Armata Pharmaceuticals est animée par une science rigoureuse et innovante, développant des thérapies bactériophages de premier ordre à fort impact, avec le potentiel de sauver des millions de vies.
L'héritage et l'expertise d'AmpliPhi Biosciences en matière de thérapie phagique ont été intégrés à Armata Pharmaceuticals, en se concentrant sur des solutions pionnières pour lutter contre la menace mondiale de la résistance aux antimicrobiens. Armata Pharmaceuticals s'engage à faire progresser le domaine grâce à une recherche et un développement de pointe, garantissant la fourniture de traitements efficaces et innovants.
Nous invitons le responsable d'AmpliPhi Biosciences à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme, mettant en évidence les contributions de l'entreprise à la recherche biotechnologique et la mission continue d'Armata Pharmaceuticals.
Key Personnel / Employees
Compare Companies Side by Side
Compare AmpliPhi Biosciences with 3 companies in Biotechnology-Research
| Comparison Field |
Am
AmpliPhi BiosciencesMain Company |
SpeeDx Pty LtdView Profile |
Locus Biosciences, I...View Profile |
Armata Pharmaceutica...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2009 | 2015 | 2019 |
|
Company Size
|
— | 51-200 | 51-200 | 51-200 |
|
City
|
Marina del Rey, California | Eveleigh, New South Wales | Morrisville, North Carolina | Los Angeles, California |
|
Country
|
United States | Australia | United States | United States |
|
Skills & Keywords
Comparing with main company
|
12 Total Skills
Bacteriophage Therapeutics
Antimicrobial Resistance
Phage Therapy
Biotechnology Research
Infectious Disease
Anti-infectives
Armata Pharmaceuticals
Antibiotic Resistance
Biotechnology
Antimicrobial resistance
Phage
Bacteriophage
|
11 Total
11 Unique
Unique Skills:
Antimicrobial Stewardship
Clinical Diagnostics
IVD
Molecular Diagnostics
Multiplex
PCR
+5
|
7 Total
7 Unique
Unique Skills:
Artificial Intelligence
Automation
Bacterial Infections
Immunology
Microbiome
Synthetic Biology
+1
|
9 Total
9 Unique
Unique Skills:
antimicrobial peptides
Clinical-Stage
Drug Development
Engineered Phage
Microbiome
Synthetic Biology
+3
|
4
Total Companies2009
Oldest Founded2
Countries37
Unique SkillsSimilar Companies
Other organizations in the same industry
Mitra bio
Biotechnology-ResearchUnlocking the secrets of skin aging with epigenetics
AVROBIO
Biotechnology-ResearchClinical-stage lentiviral gene therapy company, powered by plato®. Our vision: bring personalized ge...
Ten30 Biosciences Inc
Biotechnology-ResearchNew Class of Small Molecule Protein Degraders for Sickle Cell, Brain Diseases, and Cancer
Alternative Company Names
This company is also known as